MMI receives €17m co-investment for robotic microsurgery
Angelini Ventures and the European Investment Bank backed MMI in a €17m co-investment.
The backing supports the company behind the Symani robotic microsurgery system, which is already used in clinical settings.
MMI reports European commercial installations and regulatory clearances, with US clinical cases beginning in 2024. These deployments provide operating context for the new financing.